TITLE

Malabsorption in wasting HIV disease: diagnostic and management issues in resource-poor settings

AUTHOR(S)
Isaac, Rita; Alex, Reginald G.; Knox, Tamsin A.
PUB. DATE
July 2008
SOURCE
Tropical Doctor;Jul2008, Vol. 38 Issue 3, p133
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The author reflects on the expanding number of people dying from AIDS in resource-poor countries with limited access to highly active antiretroviral therapy (HAART). The author notes that the alarming death rates is attributed to the consequence of the combines effects of opportunistic infections, wasting in HIV diseases, and malnutrition. An overview of the treating of HIV-infected individuals to malabsorption as a potential contributory cause of wasting in HIV disease is offered.
ACCESSION #
70244672

 

Related Articles

  • Medical Resource Utilization and Cost of HIV-Related Care in the Highly Active Antiretroviral Therapy Era at a University Clinic in Sweden. Ghatnekar, Ola; Hjortsberg, Catharina; Gisslén, Magnus; Lindbäck, Stefan; Löthgren, Mickael // PharmacoEconomics;2010 Supplement, Vol. 28, p49 

    Introduction: Little is known regarding healthcare costs for HIV/AIDS patients in the era of highly active antiretroviral therapy (HAART) and subgroups of patients according to the severity and progression of HIV infection in Sweden. The objective of this study is therefore to describe the...

  • The Cost of Managing HIV Infection in Highly Treatment-Experienced, HIV-Infected Adults in France. Colin, Xavier; Lafuma, Antoine; Costagliola, Dominique; Lang, Jean-Marie; Guillon, Pascal // PharmacoEconomics;2010 Supplement, Vol. 28, p59 

    Background: Highly active antiretroviral therapy (HAART) has greatly enhanced HIV management, lowering the risk of clinical disease progression and death by substantially improving HIV-induced immune deficiency. Lower CD4 cell counts have consistently been associated with higher direct costs of...

  • Costs to Achieve Undetectable HIV RNA with Darunavir-Containing Highly Active Antiretroviral Therapy in Highly Pretreated Patients. Hill, Andrew M.; Clotet, Bonaventura; Johnson, Margaret; Stoll, Matthias; Bellos, Nicholas; Smets, Erik // PharmacoEconomics;2010 Supplement, Vol. 28, p69 

    Background: Very few studies have evaluated the cost of highly active antiretroviral therapy (HAART) per successful treatment in HIV-infected patients. Objectives: To evaluate the cost of achieving undetectable plasma HIV-RNA levels in highly treatment-experienced, HIV-1-infected adults...

  • HIV Infection Late Detection in AIDS Patients of an European City with Increased Immigration Since Mid 1990s. Carnicer-Pont, Dolors; De Olalla, Patricia G.; Caylà, Joan A. // Current HIV Research;Mar2009, Vol. 7 Issue 2, p237 

    The study goal is to identify predictors of HIV infection late detection in an European city with increased immigration, and determine the effects of HAART era in HIV infection detection. We used Barcelona city AIDS registry (1987-2006). Late testers were those diagnosed of AIDS defining illness...

  • CD4 Count is Associated with Postoperative Infection in Patients with Orthopaedic Trauma who are HIV Positive. Guild, George; Moore, Thomas; Barnes, Whitney; Hermann, Christopher // Clinical Orthopaedics & Related Research;May2012, Vol. 470 Issue 5, p1507 

    Background: Since the advent of effective antiretroviral therapy, the number of people with AIDS has increased and a certain percentage of these patients will require emergent orthopaedic surgery. Little is known regarding orthopaedic infections and the association of CD4 counts with...

  • Actualização e novos desafios na coinfecção pelos vírus VIH e VHB. Valente, Cristina // RPDI - Revista Portuguesa de Doenças Infecciosas;mai-ago2013, Vol. 9 Issue 2, p66 

    Since the advent of high active anti-retroviral therapy for human immnunodeficiency virus (HIV), there has been a significant decrease in deaths related to Acquired Immunodeficiency Syndrome (AIDS) and an increase in liver-related morbidity and mortality due the co-infection with chronic...

  • HIV-1 Prevention With ART and PrEP: Mathematical Modeling Insights Into Resistance, Effectiveness, and Public Health Impact. Celum, Connie; Hallett, Timothy B.; Baeten, Jared M. // Journal of Infectious Diseases;Jul2013, Vol. 208 Issue 2, p189 

    The article offers information on the use of antiretroviral therapy (ART) and pre-exposure prophylaxis (PrEP) for reduce the infectiousness of HIV-1–infected persons. As mentioned, the antiretroviral-based prevention, both ART and PrEP, are among the most promising strategies for reducing...

  • Gastrointestinal complications of HIV infection: changing priorities in the HAART era. Wilcox, C. M.; Saag, M. S. // Gut;Jun2008, Vol. 57 Issue 6, p861 

    It has now been some 25 years since the initial description of AIDS. Following these observations, the epidemiology, natural history and manifestations of this disease have been well characterised. Intense investigation has better characterised HIV, resulting in the development of effective drug...

  • Didanosine/nelfinavir/stavudine.  // Reactions Weekly;10/31/2009, Issue 1276, p12 

    The article describes the case of a 47-year-old man with AIDS who developed bilateral blepharoptosis secondary to lipodystrophy during highly active antiretroviral therapy (HAART) with stavudine, nelfinavir and didanosine for HIV infection. The man underwent surgery for his blepharoptosis which...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics